Bacterial vaginosis associated with HIV infection in pregnant women from North Carolina

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 20, Issue 4, 1999, Pages 382-386

  Royce, Rachel A ^a,b   Thorp, John ^a   Granados, Juan L ^a   Savitz, David A ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b IL   (United States)

Author keywords

Bacterial vaginosis; Epidemiology; HIV infection; Pregnancy; Vaginal flora

Indexed keywords

ARTICLE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION CONTROL; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PREGNANCY; PREMATURE LABOR; PRENATAL CARE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; UNITED STATES; VAGINA FLORA; VAGINITIS;

EID: 0033039297     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199904010-00009     Document Type: Article

References (15)

1. Royce R, Seña A, Gates WJ, Cohen M. Sexual transmission of HIV. N Engl J Med 1997;336:1072-8.
2. Ghys P, Fransen K, Diallo M, et al. The association between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d'Ivoire. AIDS 1997;11:F85-93.
3. Cohen M, Huffman I, Royce R, et al. Reduction of concentration of HIV-1 in semen after treatment for urethritis: implications for prevention of sexual transmission of HIV-1. Lancet 1997;349: 1868-73.
4. St. Louis M, Wasserheit J, Gayle H. Janus considers the HIV pandemic - harnessing recent advances to enhance AIDS prevention. Am J Publ Health 1997;87:10-12.
5. Wasserheit J. Epidemiologic synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992;19:61-77.
6. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomized controlled trial. Lancet 1995;346:530-6.
7. French J, McGregor J. Bacterial vaginosis: history, epidemiology, microbiology, sequelae, diagnosis, and treatment. In Borchardt K, Noble M, eds. Sexually transmitted diseases: epidemiology, pathology, diagnosis, and treatment. Boca Raton: CRC Press, 1997; 2-39.
8. Sewankambo N, Gray RH, Wawer MJ, et al. HIV-1 infections associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1997;350:546-50.
9. Cohen CR, Duerr A, Pruithithada N, et al. Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand. AIDS 1995;9:1093-7.
10. Taha T, Hoover D, Dallabetta G, et al. Bacterial vaginosis and disturbances in vaginal flora: association with increased acquisition of HIV. AIDS 1998;12:1699-706.
11. Nugent R, Krohn M, Hillier S. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol 1991;29:297-301.
12. Cook R, Redondo-Lopez V, Schmitt C, Meriwether C, Sobel J. Clinical, microbiological, and biochemical factors in recurrent bacterial vaginosis. J Clin Microbiol 1992;30:870-7.
13. Larsson P-G. Treatment of bacterial vaginosis. Int J STD AIDS 1992;3:239-417.
14. Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995;333:1732-6.
15. Hillier SL, Nugent RP, Eschenbach DA, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med 1995;333:1737-42.